Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jun 15, 2012 (Vol. 32, No. 12)

LabGuru

URL:www.labguru.com
  • Nice site design, easy to use
  • None

Here is a website that definitely knows how to catch the attention of scientists—on the home­page, in big letters, reads the phrase “do more science”. This site offers great organizational tools to the bench scientist, including a calendar on which to plan one’s experiments and a detailed “add an experiment” option. When experiments are added, the user can provide a description, write a protocol (complete with in-page timers), and add milestones to track one’s progress. The website also provides ways to organize and catalog one’s specimens, molecular reagents, miscellaneous materials, and storage boxes. All of these resources are free when an individual creates an account. (Of course, the system is built to integrate across lab members, so as to provide a central repository for reagents, etc. However, this option will cost you.) The website now has an accompanying iPad app, making it even more convenient for note-taking at the bench.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »